【摘要】 目的评估同期行经尿道膀胱肿瘤电切术(TURBt)和前列腺电切术(TURP)治疗非肌层浸润性膀胱癌合并前列腺增生患者的可行性。方法对同期行经尿道膀胱肿瘤电切术及经尿道前列腺电切术的20例非肌层浸润膀胱癌合并前列腺增生患者的临床资料进行回顾性分析。结果全部患者术中均未出现经尿道电切综合征。5～7 d后拔尿管均排尿通畅(I-PSS评分<5分)。术后随访,3例出现膀胱癌异位复发,复发率15%,复发位置均未见于膀胱颈、前列腺及尿道。结论同期行TURBt+TURP治疗非肌层浸润性膀胱癌合并前列腺增生安全可靠,不增加膀胱颈、前列腺窝和尿道的肿瘤种植性转移几率。更多还原

【Abstract】 Objective To evaluate the effect of simultaneous transurethral resection of bladder tumor(TURBT) and benign prostatic hyperplasia(TURP) on nonmuscle invasive bladder cancer with benign prostatic hyperplasia(BPH).Methods The clinical data of 20 patients with noninvasive bladder tumor combined with prostatic hyperplasia,who underwent simultaneous transurethral resection of bladder tumor and prostate were retrospectively analyzed.Results All 20 patients finished operation without transurethral resection syndromes.Urinate unobstructed after pull of the catheter for 5~7 days(I-PSS<5 scores).All patients were followed-up,and 3 cases(15%) of heterotopic recurrence bladder cancer arose.The location of recurrence was not in the bladder neck,prostatic fossa or urethra.Conclusion Simultaneous transurethral resection of bladder tumors and prostate for the patients of noninvasive bladder tumor combined with prostatic hyperplasia is safe and effective,which does not increase the chance of cancer implantation in bladder neck,prostatic fossa or urethra.更多还原